ROXIPRIN Drug Patent Profile
✉ Email this page to a colleague
When do Roxiprin patents expire, and when can generic versions of Roxiprin launch?
Roxiprin is a drug marketed by Roxane and is included in one NDA.
The generic ingredient in ROXIPRIN is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROXIPRIN?
- What are the global sales for ROXIPRIN?
- What is Average Wholesale Price for ROXIPRIN?
Summary for ROXIPRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ROXIPRIN at DailyMed |
US Patents and Regulatory Information for ROXIPRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roxane | ROXIPRIN | aspirin; oxycodone hydrochloride; oxycodone terephthalate | TABLET;ORAL | 087743-001 | Jun 4, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
